Carlyle and Consonance Partner with Orsini Specialty Pharmacy
February 11, 2022
Funds managed by global investment firm Carlyle have joined Consonance Capital Partners in a strategic partnership with Orsini Specialty Pharmacy to support expansion of patient access and high-touch support services for rare diseases, gene therapies and complex conditions. Terms were not disclosed; the investment is intended to strengthen Orsini’s service offerings for patients, manufacturers and payors and accelerate growth.
- Buyers
- Carlyle, Consonance Capital Partners
- Targets
- Orsini Specialty Pharmacy
- Industry
- Healthcare Services
- Location
- Illinois, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Carlyle Acquires Healthcare Technology Provider CNSI from Alvarez & Marsal Capital Partners
December 2, 2021
Healthcare Services
Affiliated funds managed by Carlyle have agreed to acquire CNSI from Alvarez & Marsal Capital Partners. CNSI is a provider of healthcare technology and services to state and federal clients (Medicaid/Medicare systems, claims processing, provider enrollment, analytics); Carlyle said it will partner with CNSI's management to expand and invest in the company's market-leading solutions.
-
Carlyle Acquires Tarrytown Expocare Pharmacy from Sheridan Capital Partners
November 14, 2025
Healthcare Services
Funds managed by global investment firm Carlyle have acquired Tarrytown Expocare Pharmacy from Sheridan Capital Partners, with Sheridan retaining a minority stake. Carlyle plans to support Tarrytown’s expansion of its specialized long-term care pharmacy services for the IDD and behavioral health communities across the U.S.; financial terms were not disclosed.
-
Carlyle Acquires Tarrytown Expocare Pharmacy from Sheridan Capital Partners
November 14, 2025
Healthcare Services
Funds managed by global investment firm Carlyle have completed the acquisition of Tarrytown Expocare Pharmacy from Sheridan Capital Partners, with Sheridan retaining a minority stake. Tarrytown is a specialized long-term care pharmacy serving the intellectual & developmental disability (IDD) and behavioral health communities; Carlyle said it will invest to expand the company's footprint and capabilities nationwide.
-
Carlyle Acquires Minority Stake in Resonetics
December 3, 2021
Medical Devices
Funds managed by Carlyle have acquired a significant minority equity stake in Resonetics, valuing the specialized medical device contract manufacturer at approximately $2.25 billion. Carlyle will join existing investor GTCR as a meaningful shareholder while Sverica retains a minority position; the investment will support Resonetics’ continued organic growth, international expansion and add-on acquisition strategy.
-
Carlyle Acquires SNP Schneider‑Neureither & Partner SE
April 10, 2025
Software
Global investment firm Carlyle completed its voluntary public cash takeover of SNP Schneider‑Neureither & Partner SE, taking the Heidelberg‑based software and consulting provider private. Carlyle will partner with SNP management to drive international expansion, optimize the Kyano product strategy and pursue inorganic growth opportunities, with equity provided by Carlyle Europe Partners V.
-
The Carlyle Group and Management Acquire Unison from Abry Partners
June 29, 2020
Software
Global investment firm The Carlyle Group, together with Unison management, has acquired Unison from Abry Partners. Carlyle will partner with Unison’s management to invest in and grow the company’s cloud-based procurement, supply chain and contract management software for U.S. federal agencies and government contractors.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.